Daré Bioscience Receives QIDP Designation from the FDA for DARE-BV1 for the Treatment of Bacterial Vaginosis

Author's Avatar
Aug 12, 2019
Article's Main Image

DARE-BV1 Phase 3 registrational trial initiation expected in 4th quarter 2019